Rodríguez AM, Padilla DMC, Beirana PA, Novales SCJ, Ramos GJA, Denis RE, Schwartzberg J

Idioma: Inglés
Referencias bibliográficas: 26
Paginas: 136-141
Archivo PDF: 145.69 Kb.

RESUMEN

La linfadenitis es la complicación más frecuente de la vacunación con el bacilo Calmette-Guérin (BCG) como prevención de la tuberculosis. A continuación presentamos el caso de un niño de 4 meses de edad con linfadenitis supraclavicular derecha de 2 meses de evolución, así como un caso de una niña de 5 meses de edad con linfadenitis supurativa; además realizamos una revisión exhaustiva de la literatura acerca de las complicaciones de la vacuna BCG haciendo énfasis en el diagnóstico y manejo de la linfadenitis.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Kimmel SR. Vaccine adverse events: separating myth from reality. Am Fam Physician 2002; 66(11): 2113-20.

2. Goraya JS. Bacille Calmette-Guérin lymphadenitis. Postgrad Med J 2002; 78(920): 327-9.

3. Seth V. Tubercular lymphadenitis: clinical manifestations. Indian J Pediatr 1995; 62(5): 565-70.

4. Yin HL. Mycobacterial spindle cell pseudotumor of lymph nodes after receiving BCG vaccination. Chin Med J 2004; 117(2): 308-10.

5. Barouni AS. BCG lymphadenopathy detected in a BCG-vaccinated infant. Braz J Med Biol Res 2004; 37(5): 697-700.

6. Deeks SL. Serious adverse events associated with bacilli Calmette-Guérin vaccine in Canada. Pediatr Infect Dis J 2005; 24(6): 538-44.

7. Teo SS. BCG vaccine associated suppurative lymphadenitis. Vaccine 2005; 23(20): 2676-9.

8. Sagic L. Adverse events following BCG vaccination. Med Pregl 2004, 57 suppl 1: 41-7.

9. Daoud W. Control of an outbreak of BCG complications in Gaza. Respirology 2003; 8(3): 376-8.

10. Awad R. BCG vaccine and post-BCG complications among infants in Gaza Strip 1999. East Mediterr Health J 2001; 7(1-2): 211-20.

11. Szczuka I. Adverse events following immunization with BCG vaccine in Poland 1994-2000. Przegl Epidemiol 2002; 56(2): 205-16.

12. Dourado I. Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren. Int J Tuberc Dis 2003; 7(4): 399-402.

13. Salinas-Sanz JA. Suppurative lymphadenitis as a complication of BCG vaccination. An Pediatr 2003; 58(5): 507-8.

14. Ali S. BCG lymphadenitis. Arch Dis Child 2004; 89(9): 812.

15. Hofstadler G. BCG lymphadenitis in an HIV-infected child 9.5 years after vaccination. AIDS Patient Care STDS 1998; 12(9): 677-80.

16. Hesseling AC. Resistant Mycobacterium bovis bacillus Calmette-Guérin disease: implications for management of BCG disease in human immunodeficiency virus-infected children. Pediatr Infec Dis J 2004; 23(5): 476-9.

17. Hesseling AC. Danish BCG vaccine-induced disease in human immunodeficiency virus-infected children. Clin Infect Dis 2003; 37(9): 1226-33.

18. Kainek II. Is BCG vaccine innocent? Pediatr Surg Int 1997; 12(2/3): 220-3.

19. Eriksson M. Non-tuberculous mycobacterial lymphadenitis in healthy children: another “lifestyle disease”? Acta Pediatr 2001; 90(11): 1340-2.

20. Gupta N. FNAC of bacillus Calmette-Guérin lymphadenitis masquerading as Largerhans Cell histiocytosis. Cytojournal 2004; 1(1): 6.

21. Sataynarayana S. Needle aspiration as a diagnostic tool and therapeutic modality in suppurative lymphadenitis following bacillus Calmette-Guérib vaccination. J Assoc Physicians India 2002; 50: 788-91.

22. Gupta K. Cytomorphologic patterns in Calmette-Guérin bacillus lymphadenitis. Acta Cytol 1997; 41(2): 348-50.

23. Singla A. The natural course of nonsupurative Calmette-Guérin bacillus lymphadenitis. Pediatr Infect Dis J 2002; 21(5): 446-8.

24. Goraya S. Treatment of Calmette-Guérin bacillus adenitis: a meta-analysis. Pediatr Infect Dis J 2001; 20(6): 632-4.

25. Banani SA. Needle aspiration for suppurative post-BCG adenitis. Arch Dis Child 1994; 71(5): 446-7.

26. Hengster P. Surgical treatment of bacillus Calmette-Guérin lymphadenitis. World J Surg 1997; 21(5): 520-3.